Inhibition Peroxiredoxin-2 by Capsaicin Ameliorates Rheumatoid Arthritis via ROS-Mediated Apoptosis in Fibroblast-Like Synoviocytes

Abstract

Rheumatoid arthritis (RA), a prevalent and incurable autoimmune disease globally, is characterized by the immune system attacking the body's own tissues, leading to joint inflammation and damage. Capsaicin (CAP), from Capsicum annuum L., is known for its burning sensation-inducing property and has shown various pharmacological effects, yet its specific mechanisms and targets in RA treatment remain largely unclear. This study aimed to investigate the role of CAP in RA by synthesizing CAP probes and using activity-based protein profiling. We found that CAP reduced joint swelling in arthritic mice and exerted anti-inflammatory and antiproliferative effects on fibroblast-like synoviocytes. We identified that CAP binds to PRDX2, inhibiting its antioxidant function and inducing oxidative stress and apoptosis, contributing to the antiarthritic effects. These results suggest that PRDX2 is a potential target for CAP in RA treatment, providing new insights into the molecular mechanisms and potential therapeutic strategies for RA.

Keywords

activity-based protein profiling / antioxidant / capsaicin / peroxiredoxin-2 / rheumatoid arthritis

References

[1] Q. Ding, W. Hu, R. Wang, et al., “Signaling Pathways in Rheumatoid Arthritis: Implications for Targeted Therapy,” Signal Transduction and Targeted Therapy 8, no. 1 (2023): 68.

[2] Y. He, M. Aoun, Z. Xu, and R. Holmdahl, “Shift in Perspective: Autoimmunity Protecting Against Rheumatoid Arthritis,” Annals of the Rheumatic Diseases 83, no. 5 (2024): 550-555.

[3] G. E. Thorlacius, A. Björk, and M. Wahren-Herlenius, “Genetics and Epigenetics of Primary Sjögren Syndrome: Implications for Future Therapies,” Nat Rev Rheumatol 19, no. 5 (2023): 288-306.

[4] Y. Aihaiti, X. Tuerhong, H. Zheng, Y. Cai, M. Yang, and P. Xu, “Peroxiredoxin 4 Regulates Tumor-cell-Like Characteristics of Fibroblast-Like Synoviocytes in Rheumatoid Arthritis Through PI3k/Akt Signaling Pathway,” Clinical Immunology 237 (2022): 108964.

[5] J. Wu, Z. Feng, L. Chen, et al., “TNF Antagonist Sensitizes Synovial Fibroblasts to Ferroptotic Cell Death in Collagen-induced Arthritis Mouse Models,” Nature Communications 13, no. 1 (2022): 676.

[6] J.-W. Kim, H. Jung, I.-P. Baek, et al., “Differential Effects of Periodontal Microbiome on the Rheumatoid Factor Induction During Rheumatoid Arthritis Pathogenesis,” Scientific Reports 12, no. 1 (2022): 19636.

[7] J. Hu, J. Ni, J. Zheng, et al., “Tripterygium Hypoglaucum Extract Ameliorates Adjuvant-induced Arthritis in Mice Through the Gut Microbiota,” Chinese Journal of Natural Medicines 21, no. 10 (2023): 730-744.

[8] A. Christoforow, J. Wilke, A. Binici, et al., “Design, Synthesis, and Phenotypic Profiling of Pyrano-Furo-Pyridone Pseudo Natural Products,” Angewandte Chemie International Edition 58, no. 41 (2019): 14715-14723.

[9] D. Luo, W. Li, C. Xie, et al., “Capsaicin Attenuates Arterial Calcification through Promoting SIRT6-Mediated Deacetylation and Degradation of Hif1α (Hypoxic-Inducible Factor-1 Alpha),” Hypertension 79, no. 5 (2022): 906-917.

[10] K. C. Huang, Y. F. Chiang, T. C. Huang, et al., “Capsaicin Alleviates Cisplatin-induced Muscle Loss and Atrophy in Vitro and in Vivo,” Journal of Cachexia, Sarcopenia and Muscle 14, no. 1 (2022): 182-197.

[11] J. C. Merritt, S. D. Richbart, E. G. Moles, et al., “Anti-cancer Activity of Sustained Release Capsaicin Formulations,” Pharmacology & Therapeutics 238 (2022): 108177.

[12] M. Oz, D. E. Lorke, and F. C. Howarth, “Transient Receptor Potential Vanilloid 1 (TRPV1)-independent Actions of Capsaicin on Cellular Excitability and Ion Transport,” Medicinal Research Reviews 43, no. 4 (2023): 1038-1067.

[13] X. Su, Z. Shen, Q. Yang, et al., “Vitamin C Kills Thyroid Cancer Cells Through ROS-dependent Inhibition of MAPK/ERK and PI3K/AKT Pathways via Distinct Mechanisms,” Theranostics 9, no. 15 (2019): 4461-4473.

[14] W. Li, Y. Song, X. Liang, et al., “Mutual-reinforcing Sonodynamic Therapy Against Rheumatoid Arthritis Based on Sparfloxacin Sonosensitizer Doped Concave-cubic Rhodium Nanozyme,” Biomaterials 276 (2021): 121063.

[15] M. Jeanne, V. Lallemand-Breitenbach, O. Ferhi, et al., “PML/RARA Oxidation and Arsenic Binding Initiate the Antileukemia Response of As2O3,” Cancer Cell 18, no. 1 (2010): 88-98.

[16] N. Gao, M. Rahmani, P. Dent, and S. Grant, “2-Methoxyestradiol-induced Apoptosis in human Leukemia Cells Proceeds Through a Reactive Oxygen Species and Akt-dependent Process,” Oncogene 24, no. 23 (2005): 3797-3809.

[17] Y. Zhang, J. Jiang, J. Zhang, et al., “CircDIDO1 inhibits Gastric Cancer Progression by Encoding a Novel DIDO1-529aa Protein and Regulating PRDX2 Protein Stability,” Molecular Cancer 20, no. 1 (2021): 101.

[18] K. É. Szabó-Taylor, P. Eggleton, C. A. L. Turner, et al., “Lymphocytes From Rheumatoid Arthritis Patients Have Elevated Levels of Intracellular Peroxiredoxin 2, and a Greater Frequency of Cells With Exofacial Peroxiredoxin 2, Compared With Healthy human Lymphocytes,” The International Journal of Biochemistry & Cell Biology 44, no. 8 (2012): 1223-1231.

[19] M. T. Islam, C. Sarkar, R. Hossain, et al., “Therapeutic Strategies for Rheumatic Diseases and Disorders: Targeting Redox Imbalance and Oxidative Stress,” Biomedicine & Pharmacotherapy 164 (2023): 114900.

[20] X. Liu, Q. Zhang, P. Wang, et al., “Dissection of Targeting Molecular Mechanisms of Celastrol-induced Nephrotoxicity viaa Combined Deconvolution Strategy of Chemoproteomics and Metabolomics,” International Journal of Biological Sciences 20, no. 12 (2024): 4601-4617.

[21] J. Tian, K. Chen, Q. Zhang, et al., “Mechanism of Self-Assembled Celastrol-Erianin Nanomedicine for Treatment of Breast Cancer,” Chemical Engineering Journal 499 (2024): 155709.

[22] Y. An, Q. Zhang, Y. Chen, et al., “Chemoproteomics Reveals Glaucocalyxin A Induces Mitochondria-Dependent Apoptosis of Leukemia Cells via Covalently Binding to VDAC1,” Advanced Biology 8, no. 2 (2023): e2300538.

[23] J. Tu, W. Chen, Y. Fang, et al., “PU.1 Promotes Development of Rheumatoid Arthritis via Repressing FLT3 in Macrophages and Fibroblast-Like Synoviocytes,” Annals of the Rheumatic Diseases 82, no. 2 (2022): 198-211.

[24] C. M. Weyand and J. J. Goronzy, “Immunometabolism in Early and Late Stages of Rheumatoid Arthritis,” Nature Reviews Rheumatology 13, no. 5 (2017): 291-301.

[25] Q. Zhang, P. Luo, F. Xia, et al., “Capsaicin Ameliorates Inflammation in a TRPV1-independent Mechanism by Inhibiting PKM2-LDHA-mediated Warburg Effect in Sepsis,” Cell Chemical Biology 29, no. 8 (2022): 1248-1259. e1246.

[26] D. S. Jones, A. P. Jenney, J. L. Swantek, J. M. Burke, D. A. Lauffenburger, and P. K. Sorger, “Profiling Drugs for Rheumatoid Arthritis That Inhibit Synovial Fibroblast Activation,” Nature Chemical Biology 13, no. 1 (2016): 38-45.

[27] F. I. L. Clanchy and R. O. Williams, “Ibudilast Inhibits Chemokine Expression in Rheumatoid Arthritis Synovial Fibroblasts and Exhibits Immunomodulatory Activity in Experimental Arthritis,” Arthritis & Rheumatology 71, no. 5 (2019): 703-711.

[28] J. Martel-Pelletier, D. J. Welsch, and J.-P. Pelletier, “Metalloproteases and Inhibitors in Arthritic Diseases,” Best Practice & Research Clinical Rheumatology 15, no. 5 (2001): 805-829.

[29] J. E. Pope, “Management of Fatigue in Rheumatoid Arthritis,” RMD Open 6, no. 1 (2020): e001084.

[30] L. Mullen, E.-M. Hanschmann, C. H. Lillig, L. A. Herzenberg, and P. Ghezzi, “Cysteine Oxidation Targets Peroxiredoxins 1 and 2 for Exosomal Release Through a Novel Mechanism of Redox-Dependent Secretion,” Molecular Medicine 21, no. 1 (2015): 98-108.

[31] D. D. Brand, K. A. Latham, and E. F. Rosloniec, “Collagen-induced Arthritis,” Nature Protocols 2, no. 5 (2007): 1269-1275.

[32] J.-D. Ma, J. Jing, J.-W. Wang, et al., “A Novel Function of artesunate on Inhibiting Migration and Invasion of Fibroblast-Like Synoviocytes From Rheumatoid Arthritis Patients,” Arthritis Research & Therapy 21, no. 1 (2019): 153.

[33] F. Proft, M. Torgutalp, B. Muche, et al., “Comparison of the Effect of Treatment With NSAIDs Added to Anti-TNF Therapy versus Anti-TNF Therapy Alone on the Progression of Structural Damage in the Spine Over 2 Years in Patients With Radiographic Axial Spondyloarthritis From the Randomised-controlled CONSUL Trial,” Annals of the Rheumatic Diseases 83, no. 5 (2024): 599-607.

[34] F. A. Chapa-Villarreal, M. Stephens, R. Pavlicin, M. Beussman, and N. A. Peppas, “Therapeutic Delivery Systems for Rheumatoid Arthritis Based on Hydrogel Carriers,” Advanced Drug Delivery Reviews 208 (2024): 115300.

[35] N. Biesemann, D. Margerie, C. Asbrand, et al., “Additive Efficacy of a Bispecific Anti-TNF/IL-6 Nanobody Compound in Translational Models of Rheumatoid Arthritis,” Science Translational Medicine 15, no. 681 (2023): eabq4419.

[36] J.-H. Shim, Z. Stavre, and E. M. Gravallese, “Bone Loss in Rheumatoid Arthritis: Basic Mechanisms and Clinical Implications,” Calcified Tissue International 102, no. 5 (2017): 533-546.

[37] H. A. Blair, “Capsaicin 8% Dermal Patch: A Review in Peripheral Neuropathic Pain,” Drugs 78, no. 14 (2018): 1489-1500.

[38] V. Libri, J. S. R. Gibbs, D. J. Pinato, et al., “Capsaicin 8% Patch for Treprostinil Subcutaneous Infusion Site Pain in Pulmonary Hypertension Patients,” British Journal of Anaesthesia 112, no. 2 (2014): 337-347.

[39] J. Jin, G. Lin, H. Huang, et al., “Capsaicin Mediates Cell Cycle Arrest and Apoptosis in Human Colon Cancer Cells via Stabilizing and Activating p53,” International Journal of Biological Sciences 10, no. 3 (2014): 285-295.

[40] P. Luo, Q. Zhang, T.-Y. Zhong, et al., “Celastrol Mitigates Inflammation in Sepsis by Inhibiting the PKM2-dependent Warburg Effect,” Military Medical Research 9, no. 1 (2022): 22.

[41] Q. Zhang, P. Luo, J. Chen, et al., “Dissection of Targeting Molecular Mechanisms of Aristolochic Acid-induced Nephrotoxicity viaa Combined Deconvolution Strategy of Chemoproteomics and Metabolomics,” International Journal of Biological Sciences 18, no. 5 (2022): 2003-2017.

[42] S. Wang, Z. Chen, S. Zhu, et al., “PRDX2 protects Against Oxidative Stress Induced by H. pylori and Promotes Resistance to Cisplatin in Gastric Cancer,” Redox Biology 28 (2020): 101319.

[43] W. Lu, Z. Fu, H. Wang, J. Feng, J. Wei, and J. Guo, “Peroxiredoxin 2 Knockdown by RNA Interference Inhibits the Growth of Colorectal Cancer Cells by Downregulating Wnt/β-catenin Signaling,” Cancer Letters 343, no. 2 (2014): 190-199.

[44] J.-W. Cho, “Proteomic Analysis of Psoriatic Skin Tissue for Identification of Differentially Expressed Proteins: Up-regulation of GSTP1, SFN and PRDX2 in Psoriatic Skin,” International Journal of Molecular Medicine 28, no. 5 (2011): 785-792.

[45] N. Senhaji, Y. Zaid, B. El Khalfi, et al., “Peroxiredoxin-2 Up-regulation in Inflammatory Bowel Disease: Friend or Foe?,” Journal of Gastroenterology and Hepatology 32, no. 6 (2017): 1212-1220.

[46] H. Shoda, Y. Nagafuchi, Y. Tsuchida, et al., “Increased Serum Concentrations of IL-1 Beta, IL-21 and Th17 Cells in Overweight Patients With Rheumatoid Arthritis,” Arthritis Research & Therapy 19, no. 1 (2017): 111.

[47] P. Dinesh and M. Rasool, “Berberine Inhibits IL-21/IL-21R Mediated Inflammatory Proliferation of Fibroblast-Like Synoviocytes Through the Attenuation of PI3K/Akt Signaling Pathway and Ameliorates IL-21 Mediated Osteoclastogenesis,” Cytokine 106 (2018): 54-66.

[48] R. Arora, W. A. Malla, A. Tyagi, et al., “Transcriptome Profiling of Canine Parvovirus 2 Nonstructural Gene 1(CPV2.NS1) Transfected 4T1 Mice Mammary Tumor Cells to Elucidate Its Oncolytic Effects,” International Journal of Biological Macromolecules 281 (2024): 136620.

[49] C. Chen, Y. Shu, C. Yan, et al., “Astrocyte-derived Clusterin Disrupts Glial Physiology to Obstruct Remyelination in Mouse Models of Demyelinating Diseases,” Nature Communications 15, no. 1 (2024): 7791.

[50] L. Zou, G. Zhang, L. Liu, C. Chen, X. Cao, and J. Cai, “Relationship Between PI3K Pathway and Angiogenesis in CIA Rat Synovium,” American journal of translational research 8, no. 7 (2016): 3141-3147.

[51] J. Chen, X. Lin, J. He, et al., “Artemisitene Suppresses Rheumatoid Arthritis Progression via Modulating METTL3-mediated N6-methyladenosine Modification of ICAM2 mRNA in Fibroblast-Like Synoviocytes,” Clinical and translational medicine 12, no. 12 (2022): e1148.

[52] Q. Zhang, J. Liu, H. Duan, R. Li, W. Peng, and C. Wu, “Activation of Nrf2/HO-1 Signaling: An Important Molecular Mechanism of Herbal Medicine in the Treatment of Atherosclerosis via the Protection of Vascular Endothelial Cells From Oxidative Stress,” Journal of Advanced Research 34 (2021): 43-63.

[53] X. Xu, M. Shan, C. Chu, S. Bie, H. Wang, and S. Cai, “Polysaccharides From Polygonatum Kingianum Collett & Hemsl Ameliorated Fatigue by Regulating NRF2/HO-1/NQO1 and AMPK/PGC-1α/TFAM Signaling Pathways, and Gut Microbiota,” International Journal of Biological Macromolecules 266 (2024): 131440.

[54] B. Barajas, N. Che, F. Yin, et al., “NF-E2-Related Factor 2 Promotes Atherosclerosis by Effects on Plasma Lipoproteins and Cholesterol Transport That Overshadow Antioxidant Protection,” Arteriosclerosis, Thrombosis, and Vascular Biology 31, no. 1 (2011): 58-66.

[55] H. K. Bryan, A. Olayanju, C. E. Goldring, and B. K. Park, “The Nrf2 Cell Defence Pathway: Keap1-dependent and -independent Mechanisms of Regulation,” Biochemical Pharmacology 85, no. 6 (2013): 705-717.

[56] S. Freigang, F. Ampenberger, G. Spohn, et al., “Nrf2 is Essential for Cholesterol Crystal-induced Inflammasome Activation and Exacerbation of Atherosclerosis Nrf2 is Essential for Cholesterol Crystal-induced Inflammasome Activation and Exacerbation of Atherosclerosis,” European Journal of Immunology 41, no. 7 (2011): 2040-2051.

[57] S. Fiorelli, B. Porro, N. Cosentino, et al., “Activation of Nrf2/HO-1 Pathway and Human Atherosclerotic Plaque Vulnerability:An in Vitro and in Vivo Study,” Cells 8, no. 4 (2019): 356.

[58] V. Carina, V. Costa, S. Pagani, et al., “Inhibitory Effects of Low Intensity Pulsed Ultrasound on Osteoclastogenesis Induced in Vitro by Breast Cancer Cells,” Journal of Experimental & Clinical Cancer Research 37, no. 1 (2018): 197.

[59] X. Chen, W. Gong, X. Shao, et al., “METTL3-mediated M ⁶A Modification of ATG7 Regulates Autophagy-GATA4 Axis to Promote Cellular Senescence and Osteoarthritis Progression,” Annals of the Rheumatic Diseases 81, no. 1 (2021): 85-97.

[60] P. Luo, D. Liu, Q. Zhang, et al., “Celastrol Induces Ferroptosis in Activated HSCs to Ameliorate Hepatic Fibrosis via Targeting Peroxiredoxins and HO-1,” Acta Pharmaceutica Sinica B 12, no. 5 (2022): 2300-2314.

RIGHTS & PERMISSIONS

2025 The Author(s). MedComm published by Sichuan International Medical Exchange & Promotion Association (SCIMEA) and John Wiley & Sons Australia, Ltd.